Endocrine-Related Cancer

Papers
(The H4-Index of Endocrine-Related Cancer is 24. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Interleukin-6 promotes the dedifferentiation of papillary thyroid cancer cells91
Identifying metastatic renal cell carcinoma in thyroid fine-needle aspirates by molecular testing67
Acknowledgement to reviewers55
Сytotoxic T lymphocyte-associated protein 4 (CTLA4) is overexpressed in a subset of prolactin- and growth hormone-secreting pituitary adenomas54
Deregulated kinase action in prostate cancer: molecular basis and therapeutic implications49
Prognostic of recurrence and survival in poorly differentiated thyroid cancer44
ERRATUM: Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs44
Targeting growth hormone in cancer: future perspectives39
Update on the genetics of paragangliomas36
Acknowledgement to reviewers36
Celebrating the 80th anniversary of hormone ablation for prostate cancer36
Spironolactone is associated with reduced mitotane levels in adrenocortical carcinoma patients35
Chemokines with CXC motif and their receptors in neuroendocrine neoplasms34
Genistein induces endocrine resistance in human breast cancer by suppressing H3K27 trimethylation31
MicroRNA regulation of the serine synthesis pathway in endocrine-resistant breast cancer cells30
CORRIGENDUM: GPER1 is regulated by insulin in cancer cells and cancer-associated fibroblasts29
Metabolically active brown adipose tissue in PPGL: an observational cohort study28
Radioiodine treatment: an historical and future perspective28
The genetic changes in 11p15.5-related pheochromocytomas and paragangliomas27
Lymphangioleiomyomatosis: where endocrinology, immunology and tumor biology meet27
Differential activity of specific inhibitors of transcription regulating cyclin-dependent kinases in thyroid cancer cells27
Gender-affirming care and endocrine-related cancers25
Whole-exome sequencing of rectal neuroendocrine tumors25
Therapy considerations in neuroendocrine prostate cancer: what next?24
Two miRNAs enriched in plasma extracellular vesicles are potential biomarkers for thyroid cancer24
0.16307902336121